Albitin Tablet
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
MFDS item code 201406179 · Approved 2014.12.31
This product's status changed to Expired on 2024.12.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers, gastritis, and reflux esophagitis); prevention of Mendelson syndrome
This medication is used to treat various digestive system issues such as gastric and duodenal ulcers, gastritis, and reflux esophagitis. It also suppresses excessive gastric acid secretion caused by Zollinger-Ellison syndrome and helps prevent ulcers that may occur post-surgery. Administered before anesthesia, it prevents Mendelson's syndrome and is effective in treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It is used to improve various gastrointestinal diseases.
○ Adults Usually, administer 2 tablets orally twice daily, regardless of meals, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs are usually cured within 4 weeks, and ulcers are usually cured within 8 weeks; however, the healing period may sometimes be longer, depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, in patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery.
This medication should not be used in patients undergoing dialysis or with impaired kidney function. Additionally, it should not be administered to patients who have had allergic reactions to this medication or its ingredients, patients with a history of acute porphyria, patients who have undergone gastric surgery, pregnant women or those who might become pregnant, premature infants and newborns, and patients on a dietary regimen that restricts potassium intake. Patients with liver dysfunction, a history of hypersensitivity reactions, the elderly, patients with a history of kidney diseases, and those taking non-steroidal anti-inflammatory drugs should exercise caution when administering this medication. Particularly, since it may mask symptoms of gastric cancer, patients with gastric ulcers and middle-aged or older patients who have newly developed or changed dyspeptic symptoms should be assessed for malignancy before use. Patients with gastric or duodenal ulcers who are infected with Helicobacter pylori should receive eradication therapy, and severely ill patients in intensive care or those with hypophosphatemia and patients who have difficulty swallowing should also be cautious when administering this medication. This medication can rarely cause severe allergic reactions or shock; therefore, if any abnormal symptoms appear during use, stop the medication immediately and seek appropriate treatment. Allergic symptoms such as skin rash, hives, angioedema, fever, bronchospasm, hypotension, chest pain, etc., may occur, so caution is advised. Regular blood tests are required as leukopenia, thrombocytopenia, or liver function abnormalities may appear in blood tests. Various side effects have been reported, including cardiac irregularities, gastrointestinal symptoms (nausea, vomiting, diarrhea, etc.), neurological symptoms (dizziness, drowsiness, confusion, seizures, etc.), muscle pain, skin rash, etc. If any abnormal symptoms occur, inform a healthcare provider immediately. If the medication does not provide an effect without long-term use, it is advisable to switch to another drug. Elderly patients or those with chronic lung disease, diabetes, or weakened immune systems may have an increased risk of pneumonia, requiring caution. If dizziness or drowsiness occurs while taking this medication, avoid driving or operating hazardous machinery. This medication may interact with other drugs, so particularly when taken alongside anticoagulants, frequent blood tests are necessary, and dosages should be spaced apart from certain antibiotics, anticonvulsants, antacids, etc. Pregnant or breastfeeding women should refrain from using this medication, and safety in pediatric patients has not been established, so it is advisable not to administer it in children. In the case of overdose, treatment such as vomiting or gastric lavage may be necessary, and in severe cases, it can be removed through blood dialysis. This medication decreases gastric acid secretion, which may promote bacterial proliferation in the stomach; therefore, regular screenings, including ocular examinations, are necessary during long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container that does not allow air to enter, and it is advisable to keep it at room temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness for a long time.
This medication is a round white film-coated tablet.
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.